This metabolite provides a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 somewhere around fifty% in the parent drug. Plasma concentrations of this metabolite are around 40% of People viewed for sildenafil, so which the metabolite accounts for approximately twenty% of